Cambridge Healthtech Institute’s 8th Annual

Optimizing Biologics Formulation and Stability

New Tools, Technologies, Case Studies, and Research Updates on Development of Novel Biologics

August 26-27, 2020

 

The seventh annual Optimizing Biologics Formulation and Stability conference will cover latest trends and challenges in formulations development of novel biologic formats, process optimization, manufacturing, and device and packaging considerations for existing and emerging protein therapeutics. We are seeking case studies, especially unpublished and innovative work on co-formulation, formulation of novel biologics, development and delivery of high-concentration protein formulations, effective scale-up strategies, excipient-induced instability, process challenges, fill-finish challenges, and predictive tools for rapid formulation and stability screening.

 

Coverage will include, but is not limited to:

 

  • Formulation and manufacturability of ADCs, bispecifics, other novel biologics formats, peptides, vaccines, cell-based and gene therapy
  • Co-formulations and combination products
  • Formulation approach to control protein aggregation and degradation
  • Excipient-induced protein degradation and aggregation, use of novel excipients and regulatory considerations
  • High-concentration protein formulations development: mechanism, fill-finish issues, managing viscosity and aggregation, devices, prediction, measurement of aggregation, viscosity, and solubility
  • Low-concentration formulations development
  • Product characterization, comparability, and correlation between early development studies and late-stage development studies
  • Predictive and high-throughput screening methods, forced degradation studies, new formulation technologies, DOE in formulation screening
  • New research and case studies for development of challenging lyophilization processes, fill- finish, scale-up, technology transfer, and manufacturing processes
  • Product presentation, container closure, and device engineering and its impact on formulation development and downstream manufacturing

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is February 14, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

For more details on the conference, please contact:
Nandini Kashyap, MPharm
Conference Director
Cambridge Healthtech Institute

Phone: (+1) 781-972-5406
Email: nkashyap@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K
Sherry Johnson
Senior Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1359
Email: sjohnson@healthtech.com

Companies L-Z
Carolyn Cooke
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5412
Email: ccooke@healthtech.com



Premier Sponsors:

NanotemperTechnologies

Vironova